Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
Titel:
Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
Auteur:
Gucalp, Ayca Sparano, Joseph A. Caravelli, James Santamauro, Jean Patil, Sujata Abbruzzi, Alyson Pellegrino, Christine Bromberg, Jackie Dang, Chau Theodoulou, Maria Massague, Joan Norton, Larry Hudis, Clifford Traina, Tiffany A.